It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 1999.
1999 | Hyderabad, Telangana, India | ActiveSriven Life Science Private Limited, a active private limited company, was established on 24 December 1999 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U27109TG1999PTC033135. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹2.00 M.
Formerly known as Sriven Metals And Alloys Private Limited. It upholds a active non-compliant status. Its leadership includes Indira Kadiyala (Director), Veera Venkata Srinivasa Rao Gutta (Director). Past directors included Ramakrishna Vankinanai, Nekkanti Venkateswar Rao. It holds ₹1.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Flat:505, Raaga Manor Apartments,Jai Bharat Nagar, Nizampet Road, Kukatpally,Hyderabad, Hyderabad, Telangana, 500072.
U27109TG1999PTC033135
033135
24 December 1999
₹2.00 M
₹2.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sriven Life Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Indira Kadiyala | Director | 31 Oct 2003 | Current |
| Veera Venkata Srinivasa Rao Gutta | Director | 24 Dec 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Nov 2008 | Past |
| Pramod Abcsdd | Director | 26 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sriven Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 80.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sriven Life Science had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2014 | Others | ₹4.20 M | Open |
| 18 Mar 2002 | State Bank Of Hyderabad | ₹3.40 M | Open |
| 18 Mar 2002 | State Bank Of Hyderabad | ₹3.40 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sriven Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sriven Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriven Life Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sriven Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Sriven Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was completed.
Progress on A charge with Others of Rs. 4.20 M registered on 13 Dec 2014 with Charge ID 10536632 was modified on 11 Sep 2017. was documented.
A charge with Others amounted to Rs. 4.20 M with Charge ID 10536632 was registered on 13 Dec 2014. was recorded as a recent event.
A charge with State Bank Of Hyderabad of Rs. 3.40 M registered on 18 Mar 2002 with Charge ID 90130094 was modified on 06 Dec 2004. was recorded as a recent event.
The activity Indira Kadiyala was appointed as a Director was appointed as a Director on 31 Oct 2003 & has been associated with this company since 22 years 25 days . was completed.
The CIN of Sriven Life Science Private Limited is U27109TG1999PTC033135.
Sriven Life Science Private Limited is headquartered at Flat:505, Raaga Manor Apartments,Jai Bharat Nagar, Nizampet Road, Kukatpally,Hyderabad, Hyderabad, Telangana, 500072.
Sriven Life Science Private Limited was incorporated on 24 December 1999.
The current directors of Sriven Life Science Private Limited are
The primary industry of Sriven Life Science Private Limited is Manufacturing.
Sriven Life Science Private Limited is unlisted.
The authorized capital of Sriven Life Science Private Limited is ₹2.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Sriven Life Science Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX